AGLAIA BIOMEDICAL VENTURES
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since the number of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into no... vel products is a prerequisite for success. Aglaia's focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development. Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.
AGLAIA BIOMEDICAL VENTURES
Founded:
2003-01-01
Status:
Active
Contact:
+31 30 229 6090
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Pound Sterling Dutch Server Location
Similar Organizations
TMT Investments
TMT Investments provides investors with liquid exposure to a diversified portfolio of earlier-stage technology startups.
VerteOZ
Verte Opportunity Fund invests in high-growth start-ups and speed-ups impacting opportunity zones.
Current Advisors List
Board_member
Current Employees Featured
Mark Krul Founder and Director @ Aglaia BioMedical Ventures
Founder and Director
2003-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-07 | Sapreme Technologies | Aglaia BioMedical Ventures investment in Series A - Sapreme Technologies | 15 M EUR |
| 2021-02-09 | InteRNA Technologies | Aglaia BioMedical Ventures investment in Series B - InteRNA Technologies | 18.5 M EUR |
| 2018-06-26 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience | 4.7 M EUR |
| 2018-04-11 | Mimetas | Aglaia BioMedical Ventures investment in Series B - Mimetas | 20.5 M USD |
| 2017-05-31 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience | 10.5 M CHF |
| 2017-01-19 | Cristal Therapeutics | Aglaia BioMedical Ventures investment in Venture Round - Cristal Therapeutics | 12.8 M EUR |
| 2017-01-09 | Macrophage Pharma | Aglaia BioMedical Ventures investment in Series A - Macrophage Pharma | 9 M GBP |
| 2015-12-15 | InteRNA Technologies | Aglaia BioMedical Ventures investment in Series A - InteRNA Technologies | 10.5 M USD |
| 2015-12-14 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Seed Round - Inthera Bioscience | 3.4 M EUR |
| 2010-01-29 | Merus | Aglaia BioMedical Ventures investment in Series B - Merus | 21.7 M EUR |
More informations about "Aglaia BioMedical Ventures"
Aglaia Oncology Funds | Investing in the Fight Against Cancer
Jul 11, 2024 Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and …See details»
Aglaia BioMedical Ventures - Crunchbase
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of …See details»
Aglaia Oncology Funds - LinkedIn
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early …See details»
Biotech venture capital firm Aglaia launches ... - Aglaia …
Sep 18, 2014 Aglaia’s investment philosophy focuses on impact investing, which combines financial and social returns. www.aglaia-biomedical.com. For further information, please contact: Aglaia Biomedical Ventures Karl Rothweiler …See details»
Aglaia Biomedical Ventures Fund: Performance - PitchBook
Aglaia Biomedical Ventures Fund is an early-stage venture capital fund managed by Aglaia Oncology Funds. The fund is located in Bilthoven, Netherlands. The fund targets to invest in …See details»
Aglaia BioMedical Ventures - Investments, Portfolio & Company …
Aglaia BioMedical Ventures has had . obfuscated. obfuscated. exit, which was Merus. Which industries has this organization had the most exits in? Show . Merus Merus is a biomedical …See details»
Aglaia Oncology Funds investment portfolio - PitchBook
Jun 23, 2011 Aglaia Oncology Funds General Information Company Description. Founded in 2004, Aglaia Oncology Funds is a venture capital firm based in Bilthoven, Netherlands. The …See details»
Aglaia BioMedical Ventures - Funding, Financials, Valuation
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities. Search Crunchbase. Start Free Trial . Chrome …See details»
Aglaia Oncology Funds - CB Insights
Dec 31, 2005 Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and …See details»
Aglaia BioMedical Ventures - Company Profile & Staff Directory
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of …See details»
Inthera Bioscience AG expands management team
Jun 26, 2018 About Aglaia BioMedical Ventures. Dutch venture capital firm Aglaia – through its Oncology Funds I and II – invests in ground-breaking technologies that have the potential to translate into solutions for the …See details»
Aglaia - EU-Startups
Aglaia invests in oncology drug development companies. The Aglaia team has decades of experience in cancer research and oncology drug development. Since 2004, Aglaia has built …See details»
Aglaia BioMedical Ventures - Crunchbase
Aglaia BioMedical Ventures . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar …See details»
Transforming Health: Ontario startups in decentralized and …
For biomedical innovators (drugs, devices, diagnostics), there is at least somewhat of a defined path to access the health system. This is not the case for health IT ventures, despite digital …See details»
Staff & Board - SCAN of Northern Virginia
Meet our board. At SCAN, we are committed to our mission.In order to help us fulfill that mission, we have gathered a team of committed professionals who represent excellence and integrity in …See details»
Inthera Bioscience raises CHF 10.5 million in ... - Aglaia Oncology …
Inthera Bioscience raises CHF 10.5 million in Series A financing round. June 01, 2017. Zurich, Switzerland, May 31, 2017 – Inthera Bioscience, a Swiss biopharmaceutical company …See details»
Aglaia BioMedical Ventures - Updates, News, Events ... - Crunchbase
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunitiesSee details»
Current seniors, juniors, and sophomores honored with academic …
More than 20 honors for academic achievement and leadership were awarded to current seniors, juniors, and sophomores during the Nov. 6 Undergraduate Awards ceremony held in Coley …See details»
Agiliti | Medical Equipment Company
Comprehensive onsite and depot repair services for surgical instruments, biomedical equipment and diagnostic imaging systems. View Clinical Engineering View Surgical Equipment. Medical …See details»
Aglaia BioMedical Ventures - Contacts, Employees, Board …
Aglaia BioMedical Ventures has 1 current employee profile, Founder and Director Mark Krul. Aglaia BioMedical Ventures has 1 board member or advisor, Joost Ruitenberg. Contacts. Edit …See details»